The novel aminoglycoside, ELX-02, permits CTNSW138X translational read-through and restores lysosomal cystine efflux in cystinosis

Cystinosis is a rare disorder caused by recessive mutations of the CTNS gene. Current therapy decreases cystine accumulation, thus slowing organ deterioration without reversing renal Fanconi syndrome or preventing eventual need for a kidney transplant.15-20% of cystinosis patients harbour at least o...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2019-12, Vol.14 (12), p.e0223954-e0223954
Main Authors: Brasell, Emma J, Chu, Lee Lee, Akpa, Murielle M, Eshkar-Oren, Idit, Alroy, Iris, Corsini, Rachel, Gilfix, Brian M, Yamanaka, Yojiro, Huertas, Pedro, Goodyer, Paul
Format: Article
Language:English
Subjects:
Accumulation
Age
Amino Acid Transport Systems, Neutral - physiology
Aminoglycosides
Aminoglycosides - pharmacology
Animals
Antibiotics
Autophagy
Biocompatibility
Biological Transport
Biology and Life Sciences
Cysteamine
Cystine
Cystine - metabolism
Cystinosis
Cystinosis - drug therapy
Cystinosis - metabolism
Cystinosis - pathology
Cytotoxicity
Efflux
Fanconi syndrome
Female
Gene expression
Genetics
Hemodialysis
Hereditary diseases
Inner ear
Kidney transplantation
Kidneys
Lysosomes - metabolism
Male
Medicine and Health Sciences
Mice
Mice, Inbred C57BL
Mice, Transgenic
Mutation
Nephrology
Nonsense mutation
Protein Biosynthesis
Protein synthesis
Proteins
Research and Analysis Methods
Toxicity
Transcription
Translation
Transplants & implants
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cystinosis is a rare disorder caused by recessive mutations of the CTNS gene. Current therapy decreases cystine accumulation, thus slowing organ deterioration without reversing renal Fanconi syndrome or preventing eventual need for a kidney transplant.15-20% of cystinosis patients harbour at least one nonsense mutation in CTNS, leading to premature end of translation of the transcript. Aminoglycosides have been shown to permit translational read-through but have high toxicity level, especially in the kidney and inner ear. ELX-02, a modified aminoglycoside, retains it read-through ability without the toxicity. We ascertained the toxicity of ELX-02 in cells and in mice as well as the effect of ELX-02 on translational read-through of nonsense mutations in cystinotic mice and human cells. ELX-02 was not toxic in vitro or in vivo, and permitted read-through of nonsense mutations in cystinotic mice and human cells. ELX-02 has translational read-through activity and produces a functional CTNS protein, as evidenced by reduced cystine accumulation. This reduction is comparable to cysteamine treatment. ELX-02 accumulates in the kidney but neither cytotoxicity nor nephrotoxicity was observed.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0223954